4//SEC Filing
Pay Paul William 4
Accession 0001778480-19-000003
CIK 0001540159other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 6:03 PM ET
Size
6.3 KB
Accession
0001778480-19-000003
Insider Transaction Report
Form 4
Pay Paul William
Director
Transactions
- Award
Stock Option (right to buy)
2019-07-26+1,820→ 32,399 totalExercise: $2.16Exp: 2027-09-26→ Common Shares (1,820 underlying)
Footnotes (4)
- [F1]Represents additional options to purchase common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa") and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.
- [F2]All share numbers and exercise prices reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
- [F3]This option vests and becomes exercisable 1/3 on September 26, 2018, and monthly thereafter through September 26, 2020. This option was issued in replacement of an option to purchase shares of Edesa.
- [F4]In Canadian currency.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001778480
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 6:03 PM ET
- Size
- 6.3 KB